Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate
Denosumab May Help Prevent Bone Loss
Past Highlights
Results:
1 -6 of 6
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
Last Modified:
6/1/1991
1.
Phase II Study of DuP 937 Administered Once Every Three Weeks in Patients with Refractory Solid Tumors (Summary Last Modified 06/91)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Completed
18 and over
GUMC-25190
NCI-V91-0048
Last Modified:
12/1/1991
2.
Phase II Study of DuP 937 in Patients with non-Small Cell Lung Cancer (Summary Last Modified 12/91)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
18 and over
CAN-NCIC-IND57
NCI-V91-0146, IND57
Last Modified:
12/1/1991
3.
Phase II Study of DuP 937 in Patients with Metastatic Malignant Melanoma (Summary Last Modified 12/91)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
18 and over
CAN-NCIC-IND56
NCI-V91-0145, IND56
Last Modified:
2/1/1992
4.
Phase II Study of DuP 937 in Patients with Metastatic Colorectal Cancer (Summary Last Modified 02/92)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
18 and over
CAN-NCIC-IND58
NCI-V91-0147, IND58
Last Modified:
1/1/1989
5.
Phase I Study of Chemotherapy with CI-937 Given As a Single Intravenous Bolus Every Three to Four Weeks in Adults with Locally Advanced or Metastatic Solid Tumors (Summary Last Modified 01/89)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Closed
18 and over
CAN-NCIC-IND43
NCI-V88-0565, IND43
Last Modified:
1/1/1989
6.
Phase I Chemotherapy with CI-937 Given Weekly for Three Weeks Every Five Weeks in Adults with Locally Advanced or Metastatic Solid Tumors (Summary Last Modified 01/89)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Closed
18 and over
CAN-NCIC-IND44
NCI-V88-0564, IND44
Select All on One Page
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute